Improving Study Outcomes: A Site Perspective

As a means to increase trial efficiency, sponsors and CROs are moving towards site centricity.

In our live fireside chat and Q&A, “Improving Study Outcomes: A Site Perspective”,  Wade Wirta from Medidata and Christine Pierre from SCRS will provide their insights into achieving better trial outcomes, and will discuss:

  • The requests that sponsors often make to sites that hinder patient recruitment and adversely affect enrollment targets 
  • The technology pain points sites experience when running a clinical trial 
  • What measures are sites taking to increase study quality, consistency and compliance

Webinar Details:

Date: Wednesday, September 13, 2017
Time: 12:00 - 12:45 PM EST

Speakers:

Christine Pierre

Christine Pierre
President, SCRS

Christine Pierre is an internationally recognized expert on the global investigative site landscape and trends, site management, patient recruitment and retention, and operational management change to facilitate collaboration between industry and sites. She has conducted and contributed to research on site-related topics, leading to meaningful change and stronger site partnerships and sustainability. Her commitment to Best Site Practices and site sustainability has contributed to an industry-wide understanding of this critical relationship and improvements in management strategy and execution. Ms. Pierre was the founder of RxTrials in the early 1990s, one of the first Investigative Site Networks. She is currently the President of the Society for Clinical Research Sites, a global trade organization representing over 2,600 sites in 42 countries and remains passionate and committed to site sustainability.

Wade Wirta
Managing Director, Medidata Balance®

As Managing Director of Balance, Medidata’s innovative RTSM solution, Wade has an extensive industry background of over 20 years in technology solution delivery within Pharmaceutical R&D, focusing on Development and Clinical Operations, Clinical Supply Chain, and eClinical services. He established and implemented the product and services strategy for the pre-clinical and clinical supply chain continuum for all drug development phases for a leading pharma, and received a Bachelor of Arts in Computer Science from the University of Maine at Orono, and a certification in the PRINCE II project management.

Registration for this event has ended.